Susquehanna International Group, LLP Janux Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$35.29 - $50.26 $1.79 Million - $2.54 Million
50,600 Added 73.98%
119,000 $5.41 Million
Q2 2024

Aug 15, 2024
SELL
$35.12 - $64.78 $744,544 - $1.37 Million
-21,200 Reduced 23.66%
68,400 $2.87 Million
Q1 2024

May 07, 2024
BUY
$7.93 - $49.75 $710,528 - $4.46 Million
89,600 New
89,600 $3.37 Million

Others Institutions Holding JANX

# of Institutions
166
Shares Held
37.6M
Call Options Held
85.3K
Put Options Held
654K
View Full List

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.34B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email